Exergaming Program for Heart Failure Patients
Effects of Exergaming to Reduce Sedentary Time in Inactive Patients With Heart Failure
Recruiting
N/A
Interventional Study
Cardiovascular Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 750 (estimated)
- Sponsor
- Linkoeping University · Government
Who this trial is looking for
This trial is looking for people with heart failure who are not active. Participants will be assigned to either get advice on activity or use a special exergame for 3 months to help them move more and improve their health.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with heart failure.
- I am physically inactive.
- I am older than 18 years.
- I speak or understand the local language.
- I want to use a smartphone for the study.
You may not be able to join if
- I cannot use an exergame due to vision or hearing problems.
- I cannot perform the 6-minute walk test.
- I am unable or unwilling to wear an activity monitor.
- I am currently in a rehabilitation program.
- I do not want to play an exergame.
- I have a condition that could prevent me from benefiting from this exercise.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this to determine the effect of tailored exergaming for inactive patients with heart failure to reduce their sedentary time, improve their daily physical activity, exercise capacity, decrease frailty and improve health-related quality of life.
Participants will, on a background of standard guideline-directed medical therapy patients, be randomised to tailored activity advice (control)…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Diagnosed with symptomatic HF (NYHA II-IV) as diagnosed by cardiologist, (independent of Ejection Fraction: Patients with a preserved ejection fraction (HFpEF), mid-range ejection fraction (HFmrREF) or reduced ejection fraction (HFrEF) can be included.
2. Clinically stable
3.…
Contacts